Careers Media center Contacts

STREPTOMYCIN




Active substance: streptomycin

ATC: J01G A01

How supplied: Powder for injection

Dosage form
Powder for injection intramuscular adm. intratracheal adm. intracavernous.

Active ingredient
1 vial contains streptomycin sulfate sterile recalculated to streptomycin 0.5 g or 1.0 g.

Indications
Treatment of newly detected pulmonary tuberculosis and tuberculous lesions of other organs. Patients who were treated earlier, it is advisable to prescribe medication after laboratory detection of sensitivity to drug patient isolated mycobacteria. Infectious-inflammatory processes of different localization, caused by gram-positive and gram-negative microorganisms sensitive to the drug: pneumonia caused by klebsiella, endocarditis, plague, tularemia, brucellosis.

 

 

ATTENTION!

The following information is intended for medical and pharmaceutical professionals only and can be used exclusively in professional activities.

ARE YOU A MEDICAL AND/OR PHARMACEUTICAL PROFESSIONAL?

(submitting the answer, you bear full responsibility for the accuracy of the information provided)


The presented package image matches the product design registered with the Ukrainian regulatory authorities.

If you have noticed any differences, please call us at +380 44 490 75 22

PHARMACOVIGILANCE

If you have information about any adverse effects or other drug-related problems, please fill in the form